Recent works suggest that HER2 is a driver of cancer stem-like phenotype in luminal estrogen receptor-positive (ERp) breast cancers, in the absence of HER2 gene amplification, and in breast cancers with amplification of HER2 receptor [21, 22]. The gene discussed is ERBB2; the disease is breast carcinoma.